|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Subscription Information
Editorial Office
Publish with CMH
Instructions for Authors
Peer Review and Publishing
Checklist
E-Submission
Copyright Transfer Form
Journal Archive
Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Clin Mol Hepatol
Search
Author Index
Current Issue
> Browse Articles > Current Issue
Reviews
1
Recent research trends and updates on nonalcoholic fatty liver disease
Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn, On behalf of the Korean Association for the Study of the Liver (KASL)-Korea Nonalcoholic fatty liver Study Group (KNSG)
Clin Mol Hepatol.
2019;25(1):1-11. Published online August 8, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0037
Cited By 2
12
Pathologic differential diagnosis of metastatic carcinoma in the liver
Jeong Hwan Park, Jung Ho Kim
Clin Mol Hepatol.
2019;25(1):12-20. Published online October 5, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0067
21
Radiomics and radiogenomics of primary liver cancers
Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu
Clin Mol Hepatol.
2019;25(1):21-29. Published online November 16, 2018
DOI:
https://doi.org/10.3350/cmh.2018.1007
Cited By 1
30
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Clin Mol Hepatol.
2019;25(1):30-36. Published online January 23, 2019
DOI:
https://doi.org/10.3350/cmh.2018.0061
Editorials
37
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
Young Woo Eom, Soon Koo Baik
Clin Mol Hepatol.
2019;25(1):37-39. Published online December 11, 2018
DOI:
https://doi.org/10.3350/cmh.2018.1011
40
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
Won Kim
Clin Mol Hepatol.
2019;25(1):40-41. Published online December 28, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0101
Original Articles
42
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol.
2019;25(1):42-51. Published online November 19, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0029
Cited By 1
52
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol.
2019;25(1):52-64. Published online October 23, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0040
65
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol.
2019;25(1):65-73. Published online February 25, 2019
DOI:
https://doi.org/10.3350/cmh.2018.0070
74
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
Clin Mol Hepatol.
2019;25(1):74-85. Published online February 28, 2019
DOI:
https://doi.org/10.3350/cmh.2018.0072
Letter to the Editor
86
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim
Clin Mol Hepatol.
2019;25(1):86-91. Published online August 28, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0005
Cited By 1
> Browse Articles > Current Issue
